logo

PHAT

PhathomยทNASDAQ
--
--(--)
--
--(--)

PHAT Profile

Phathom Pharmaceuticals, Inc.

A biopharmaceutical company focused on developing novel treatments for gastrointestinal diseases and disorders

Pharmaceutical
01/09/2018
10/25/2019
NASDAQ Stock Exchange
427
12-31
Common stock
100 Campus Drive , Suite 102 , Florham Park , New Jersey 07932
--
Phathom Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on January 9, 2018. The Company is a biopharmaceutical company focused on the development and commercialization of new therapies for the treatment of gastrointestinal diseases or GI diseases.